Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

46 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A systematic approach to weaning from extracorporeal membrane oxygenation in patients with refractory cardiac failure.
Mørk SR, Frederiksen CA, Nielsen RR, Lichscheidt E, Christensen S, Greisen JR, Tang M, Vase H, Løgstrup BB, Mellemkjaer S, Wiggers HS, Mølgaard H, Poulsen SH, Terkelsen CJ, Eiskjaer H. Mørk SR, et al. Among authors: nielsen rr. Acta Anaesthesiol Scand. 2021 Aug;65(7):936-943. doi: 10.1111/aas.13814. Epub 2021 Mar 27. Acta Anaesthesiol Scand. 2021. PMID: 33728635
Cardiovascular and metabolic effects of 48-h glucagon-like peptide-1 infusion in compensated chronic patients with heart failure.
Halbirk M, Nørrelund H, Møller N, Holst JJ, Schmitz O, Nielsen R, Nielsen-Kudsk JE, Nielsen SS, Nielsen TT, Eiskjaer H, Bøtker HE, Wiggers H. Halbirk M, et al. Am J Physiol Heart Circ Physiol. 2010 Mar;298(3):H1096-102. doi: 10.1152/ajpheart.00930.2009. Epub 2010 Jan 15. Am J Physiol Heart Circ Physiol. 2010. PMID: 20081109 Free article. Clinical Trial.
Suppression of circulating free fatty acids with acipimox in chronic heart failure patients changes whole body metabolism but does not affect cardiac function.
Halbirk M, Nørrelund H, Møller N, Schmitz O, Gøtzsche L, Nielsen R, Nielsen-Kudsk JE, Nielsen SS, Nielsen TT, Eiskjær H, Bøtker HE, Wiggers H. Halbirk M, et al. Am J Physiol Heart Circ Physiol. 2010 Oct;299(4):H1220-5. doi: 10.1152/ajpheart.00475.2010. Epub 2010 Aug 13. Am J Physiol Heart Circ Physiol. 2010. PMID: 20709866 Free article. Clinical Trial.
A protocol for a randomised, double-blind, placebo-controlled study of the effect of LIraglutide on left VEntricular function in chronic heart failure patients with and without type 2 diabetes (The LIVE Study).
Jorsal A, Wiggers H, Holmager P, Nilsson B, Nielsen R, Boesgaard TW, Kumme A, Møller JE, Videbæk L, Kistorp C, Gustafsson I, Tarnow L, Flyvbjerg A. Jorsal A, et al. BMJ Open. 2014 May 20;4(5):e004885. doi: 10.1136/bmjopen-2014-004885. BMJ Open. 2014. PMID: 24844271 Free PMC article. Clinical Trial.
Effect of tighter glycemic control on cardiac function, exercise capacity, and muscle strength in heart failure patients with type 2 diabetes: a randomized study.
Nielsen R, Wiggers H, Thomsen HH, Bovin A, Refsgaard J, Abrahamsen J, Møller N, Bøtker HE, Nørrelund H. Nielsen R, et al. BMJ Open Diabetes Res Care. 2016 Apr 29;4(1):e000202. doi: 10.1136/bmjdrc-2016-000202. eCollection 2016. BMJ Open Diabetes Res Care. 2016. PMID: 27158520 Free PMC article.
Effect of liraglutide, a glucagon-like peptide-1 analogue, on left ventricular function in stable chronic heart failure patients with and without diabetes (LIVE)-a multicentre, double-blind, randomised, placebo-controlled trial.
Jorsal A, Kistorp C, Holmager P, Tougaard RS, Nielsen R, Hänselmann A, Nilsson B, Møller JE, Hjort J, Rasmussen J, Boesgaard TW, Schou M, Videbaek L, Gustafsson I, Flyvbjerg A, Wiggers H, Tarnow L. Jorsal A, et al. Eur J Heart Fail. 2017 Jan;19(1):69-77. doi: 10.1002/ejhf.657. Epub 2016 Oct 28. Eur J Heart Fail. 2017. PMID: 27790809 Free article. Clinical Trial.
46 results